Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Rev Bras Epidemiol ; 26: e230026, 2023.
Article in English, Portuguese | MEDLINE | ID: covidwho-2319329

ABSTRACT

OBJECTIVE: To analyze the use of ivermectin as COVID-19 prevention method by the population of Mato Grosso in 2020. METHODS: This is a home-based survey, carried out between September and October 2020, in 10 pole cities of the socioeconomic regions of State. The use of ivermectin was evaluated through the question: "Did you take ivermectin to prevent COVID-19?". Sociodemographic variables (sex, age group, education, family income), current work situation, being benefitted by government financial programs, as well as symptoms, seroprevalence of antibodies against SARS-CoV-2, and previous diagnosis of COVID-19 were evaluated. Prevalence and their associations were estimated using the chi-square test. RESULTS: 4.206 individuals were evaluated for prevalence of ivermectin use; 58.3% of the individuals responded positively, this rate being higher in the municipalities of the western region of the state (66.6%). There was no significant difference between sexes, but the prevalence was higher among people aged 50-59 years (69.7%), who were white (66.5%), with complete higher education or more (68.8%) and higher family income (≥3 minimum wages-64.2%). The use of this drug was even higher among participants who considered their knowledge of the disease good or very good (65.0%), who reported having symptoms of COVID-19 (75.3%), and who had been previously diagnosed with the disease (91.2%). CONCLUSION: There was a high prevalence of use of ivermectin as a method to prevent covid-19 by the population of Mato Grosso, indicating the need for strategies to inform the population about the risks of off-label use of drugs and to combat the advertising of drugs that are ineffective against COVID-19.


Subject(s)
COVID-19 , Humans , Brazil/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , Cross-Sectional Studies , Ivermectin/therapeutic use , Pandemics , Prevalence , SARS-CoV-2 , Seroepidemiologic Studies
2.
Sao Paulo Med J ; 2022 Oct 28.
Article in English | MEDLINE | ID: covidwho-2308130

ABSTRACT

BACKGROUND: The coronavirus disease (COVID-19) pandemic has adversely affected the health of the global population, with sleep quality being one of the affected parameters. OBJECTIVES: To evaluate sleep quality and its associated factors in adults during the COVID-19 pandemic in Brazil. DESIGN AND SETTING: A population-based cross-sectional serological survey of 1,762 adults in the Iron Quadrangle region of Brazil. METHODS: The Pittsburgh Sleep Quality Index was used to assess sleep quality. Sociodemographic variables, health conditions, health-related behaviors, anxiety, vitamin D levels, weight gain/loss, and pandemic characteristics were assessed using a structured questionnaire. Univariate and multivariate analyses using Poisson regression with robust variance were performed to identify factors associated with sleep quality. RESULTS: More than half of the participants reported poor sleep quality (52.5%). Multivariate analysis revealed that the factors associated with poor sleep quality included living alone (prevalence ratio [PR] = 1.34; 95% confidence interval [CI]: 1.04-1.73), anxiety disorder (PR = 1.32; 95% CI: 1.08-1.62), 5.0% weight loss (PR = 1.21; 95% CI: 1.02-1.44), 5.0% weight gain (PR = 1.27; 95% CI: 1.03-1.55), vitamin D deficiency (PR = 1.16; 95% CI: 1.01-1.35), and COVID-19 symptoms (PR = 1.29; 95% CI: 1.10-1.52). CONCLUSIONS: Our study revealed that more than half of the participants experienced poor sleep quality during the COVID-19 pandemic. Factors associated with poor sleep quality included vitamin D deficiency and weight changes related to the pandemic.

3.
Cad Saude Publica ; 38(11): e00106622, 2023.
Article in English | MEDLINE | ID: covidwho-2294045

ABSTRACT

This study aimed to estimate prevalence of loneliness among older Brazilian adults over the first seven months of the COVID-19 pandemic and to identify the predictors of loneliness trajectories. Pre-pandemic data derived from face-to-face interviews of participants of the 2019-2020 Brazilian Longitudinal Study of Aging (ELSI-Brazil), which is a nationally representative study of community-dwelling individuals aged 50 years and over. Pandemic data were based on three rounds of telephone interviews among those participants, conducted from May to October 2020. Loneliness was measured by a single-item question, considering those who had at least two repeated measures. Explanatory variables included depression, living alone, leaving home in the last week, and virtual connectedness in the last month. Mixed-effects logistic regression was used to estimate odds ratios with their 95% confidence intervals (95%CI) and to investigate loneliness trajectories and their predictors. In total, 5,108 participants were included. The overall prevalence of loneliness in the pre-pandemic period was 33.1% (95%CI: 29.4-36.8), higher than the pandemic period (round 1: 23.6%, 95%CI: 20.6-26.9; round 2: 20.5%, 95%CI: 17.8-23.5; round 3: 20.6%, 95%CI: 17.1-24.6). A significant interaction (p ≤ 0.05) was evidenced only between depression and time; participants with depression showed a greater reduction in loneliness levels. Although loneliness levels in Brazil have decreased during the pandemic, this pattern is not present for all older adults. Individuals with depression had a more significant reduction, probably due to feeling closer to their social network members during the stay-at-home recommendations.


Subject(s)
COVID-19 , Humans , Middle Aged , Aged , COVID-19/epidemiology , Loneliness , Brazil/epidemiology , Pandemics , SARS-CoV-2 , Longitudinal Studies
4.
Nutrition ; 110: 112008, 2023 06.
Article in English | MEDLINE | ID: covidwho-2256576

ABSTRACT

OBJECTIVES: This study aimed to evaluate the association of vitamin D with sleep quality during the COVID-19 pandemic and the influence of daily sunlight on this association. METHODS: This cross-sectional, population-based study among adults stratified by multistage probability cluster sampling was conducted from October to December 2020 in the Iron Quadrangle region of Brazil. The outcome was sleep quality, evaluated by the Pittsburgh Sleep Quality Index. Vitamin D (25-hydroxyvitamin D) concentrations were determined by indirect electrochemiluminescence and a deficiency was classified as 25(OH)D < 20 ng/mL. To assess sunlight, the average daily sunlight exposure was calculated and was classified as insufficient when less than 30 min/d. Multivariate logistic analysis was used to estimate the association between vitamin D and sleep quality. A directed acyclic graph was used to select minimal and sufficient sets of adjustment variables for confounding from the backdoor criterion. RESULTS: In a total of 1709 individuals evaluated, the prevalence of vitamin D deficiency was 19.8% (95% CI, 15.5-24.9%), and the prevalence of poor sleep quality was 52.5% (95% CI, 48.6-56.4%). In multivariate analysis, vitamin D was not associated with poor sleep quality in individuals with sufficient sunlight. Moreover, in individuals with insufficient sunlight, vitamin D deficiency was associated with poor sleep quality (odds ratio [OR], 2.02; 95% CI, 1.10-3.71). Furthermore, each 1-ng/mL increase in vitamin D levels reduced the chance of poor sleep quality by 4.2% (OR, 0.96; 95% CI, 0.92-0.99). CONCLUSIONS: Vitamin D deficiency was associated with poor sleep quality in individuals with insufficient exposure to sunlight.


Subject(s)
COVID-19 , Vitamin D Deficiency , Adult , Humans , Sunlight , Brazil/epidemiology , Sleep Quality , Cross-Sectional Studies , Pandemics , COVID-19/complications , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/complications , Calcifediol , Vitamins
5.
Cien Saude Colet ; 28(2): 331-336, 2023 Feb.
Article in Portuguese, English | MEDLINE | ID: covidwho-2233580

ABSTRACT

This paper aims to assess the magnitude and profile of deaths from post-COVID conditions in Brazil. Descriptive study based on preliminary data from the 2021 Mortality Information System. Records with ICD code B94.8 as the Basic Cause and with code U09 in some lines of part I or II of the declaration were considered for analysis. The distribution of deaths by geographic region, semester of occurrence, sex, age group, ethnicity/skin color, schooling, and place of occurrence was evaluated. We identified 2,948 deaths from conditions subsequent to COVID-19 were recorded, ranging from 0.5 deaths per 1,000 records in the Northeast Region to 3.6/1,000 in the Midwest Region. More than half occurred among males (58.0%), those aged 60 years or older (66.9%), and whites (51.8%). Conclusion: Deaths from post-COVID conditions had distinct sociodemographic characteristics between regions.


O objetivo deste artigo é avaliar a magnitude e o perfil dos óbitos por condições posteriores à COVID-19 no Brasil. Estudo descritivo com base nos dados preliminares de registro de óbitos do Sistema de Informação sobre Mortalidade ocorridos em 2021. Foram considerados os registros com código CID B94.8 como causa básica e com código U09 em alguma linha da parte I ou II da declaração de óbito. Foi avaliada a distribuição dos óbitos por região geográfica, semestre de ocorrência, sexo, faixa etária, raça/cor, escolaridade e local de ocorrência. Foram registrados 2.948 óbitos por condições posteriores à COVID-19, variando de 0,5 óbito por 1.000 registros na região Nordeste a 3,6/1.000 na região Centro-Oeste. Mais da metade ocorreu entre o sexo masculino (58,0%), aqueles com 60 anos ou mais de idade (66,9%) e de cor da pele branca (51,8%). Os óbitos por condições posteriores à COVID-19 apresentaram características sociodemográficas distintas entre as regiões.


Subject(s)
COVID-19 , Post-Acute COVID-19 Syndrome , Male , Humans , Brazil/epidemiology , Educational Status , Ethnicity
6.
Rev Assoc Med Bras (1992) ; 68(7): 928-934, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1987229

ABSTRACT

OBJECTIVE: This study aimed to analyze the association between self-reported symptoms and seroprevalence against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the population of Mato Grosso. METHODS: A household-based survey was conducted on 4,206 adults from 10 municipalities of Mato Grosso, in the Brazilian Midwest, who were selected by cluster sampling in three stages. Questionnaires were applied between September and October 2020, and chemiluminescence was used for the quantitative determination of immunoglobulin G (IgG) antibodies against the S1 and S2 proteins of SARS-CoV-2. RESULTS: Approximately half (47.0%) of individuals with SARS-CoV-2 antibodies (12.5%) reported having no symptoms. The most prevalent symptoms among individuals with antibodies were body pain (37.0%), fever (32.9%), and smell and taste change (28.7%). The search for a basic health unit was predominant (45.0%) as the first service, and only 5.3% reported being hospitalized. CONCLUSION: A high proportion of asymptomatic cases of coronavirus disease 2019 (COVID-19) was identified in the general population, even among older adults and individuals with comorbidities.


Subject(s)
COVID-19 , SARS-CoV-2 , Aged , Antibodies, Viral , Brazil/epidemiology , COVID-19/epidemiology , Humans , Self Report , Seroepidemiologic Studies
7.
Cien Saude Colet ; 27(8): 3157-3170, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1963149

ABSTRACT

This article aims to analyze the factors associated with suicidal ideation in the COVID-19 pandemic. A cross-sectional home-based survey, with three-stage cluster sampling, was conducted with 4,203 adults from ten municipalities in the Mato Grosso, Brazil. The data collection was carried households to assessment of sociodemographic characteristics, substance use and behavior in the pandemic. The Level 1 Symptom Cross Scale was used to identify suicidal ideation and aspects of mental health (somatic symptoms, sleep disturbances, dissociation, depression, anger, mania, anxiety, thoughts, substance use and memory). Chemiluminescence was used to detect IgG anti-SARS-CoV-2 antibodies. The prevalence of suicidal ideation was 19.2%, and the associated with increased consumption of alcohol (RP=1.16), smoking (RP=1.30), COVID-19 symptoms (RP=1.03), having one's life affected (RP=1.04), mental illness (RP=1.09) somatic symptoms (RP=1.15), sleep disturbance (RP=1.30), dissociation (RP=1.24), depression (RP=1.24), anger (RP=1.11), anxiety (RP=1.26), substance use (RP=1.19), drug prescription use (RP=1.18) and memory (RP=1.87). Highlights the high prevalence of suicidal ideation related to COVID-19 symptoms, changes in behavior post-pandemic and mental health factors.


Subject(s)
COVID-19 , Medically Unexplained Symptoms , Sleep Wake Disorders , Adult , Anxiety/epidemiology , Anxiety/psychology , Brazil/epidemiology , COVID-19/epidemiology , Cross-Sectional Studies , Depression/epidemiology , Depression/psychology , Humans , Pandemics , Sleep Wake Disorders/epidemiology , Suicidal Ideation
8.
Rev Bras Epidemiol ; 25(Supl 1): e220020, 2022.
Article in English, Portuguese | MEDLINE | ID: covidwho-1910768

ABSTRACT

OBJECTIVE: To analyze the prognostic factors for death from COVID-19 among cancer patients. METHODS: This is a retrospective study based on data recorded in the reporting system for COVID-19 hospitalizations in Mato Grosso. We assessed cases of cancer patients reported between April 2020 and June 2021. We calculated absolute and relative frequencies of sociodemographic variables, hospital care variables, and comorbidities, as well as mean, median, and standard deviation of age and length of stay. Odds ratios and their respective 95% confidence intervals (95%CI) - crude and adjusted - were estimated using the logistic regression model. RESULTS: We analyzed 948 cancer patients hospitalized for COVID-19 in Mato Grosso, with a mean age of 59.7 years. The proportion of deaths was 34.5%, the mortality rate was 3.73 deaths/day (95%CI 3.35-4.16), and the median time between admission and death was 18 days. The likelihood of death was greater among patients aged 60 years or older, with chronic lung disease, who were admitted directly to intensive care units, and required mechanical ventilation at the time of admission. Patients hospitalized from April to December 2020 and January to March 2021 had a greater chance of death than those hospitalized between April and June 2021. CONCLUSION: The likelihood of death from COVID-19 was greater in cancer patients hospitalized before their vaccination period in the state, as well as among older individuals and those admitted in worse clinical conditions.


Subject(s)
COVID-19 , Neoplasms , Brazil/epidemiology , Hospital Mortality , Hospitalization , Humans , Middle Aged , Retrospective Studies , SARS-CoV-2
9.
Cad Saude Publica ; 38(5): e00093021, 2022.
Article in Portuguese | MEDLINE | ID: covidwho-1892412

ABSTRACT

Seroprevalence data provide relevant information on the development and progression of the COVID-19 pandemic. The study aimed to estimate the prevalence of SARS-CoV-2 antibodies in Mato Grosso State, Brazil, and its distribution according to sociodemographic and economic characteristics. This population-based serological survey was conducted in September-October 2020 in individuals 18 years or older in ten municipalities (counties) in the state of Mato Grosso. Interviews and collection of biological samples were conducted in the households, and determination of IgG antibodies to SARS-CoV-2 was performed with chemiluminescence. A total of 4,306 individuals were evaluated, and COVID-19 prevalence was estimated at 12.5% (95%CI: 10.5; 14.7), ranging from 7.4% to 24.3% between municipalities. No significant differences were found in prevalence of infection according to race/color, schooling, or family income, but lower prevalence was seen in individuals with a pensioner living in the same household, who did not receive emergency financial aid, and whose family income had not decreased after social distancing measures during the epidemic. Estimated prevalence of SARS-CoV-2 antibodies in this population-based survey is essential to measure the magnitude of the disease and will back measures to confront and control the pandemic.


Dados de soroprevalência oferecem informações relevantes relacionadas ao desenvolvimento e progressão de pandemia da COVID-19. Estimar a prevalência de anticorpos anti-SARS-CoV-2 em Mato Grosso, Brasil e sua distribuição segundo características sociodemográficas e econômicas. Inquérito soroepidemiológico de base populacional conduzido entre setembro e outubro de 2020, com indivíduos de 18 anos ou mais de idade, em dez municípios do Estado de Mato Grosso. As entrevistas e coleta de material biológico foram realizadas em domicílio, e a determinação de anticorpos IgG contra o SARS-CoV-2 foi feita por meio da quimioluminescência. Foram 4.306 indivíduos avaliados, e a prevalência de COVID-19 foi estimada em 12,5% (IC95%: 10,5; 14,7), variando de 7,4% a 24,3% entre os municípios. Não foram verificadas diferenças na prevalência da infecção segundo raça/cor da pele, escolaridade ou renda familiar, entretanto verificou-se menor prevalência entre indivíduos que residiam com algum morador que recebia aposentadoria, que não receberam auxílio financeiro emergencial e que a renda familiar não diminuiu após as medidas de distanciamento social para enfrentamento da epidemia. A prevalência de anticorpos contra SARS-CoV-2 estimada nesta pesquisa de base populacional é essencial para conhecer a magnitude da doença no estado e subsidiará ações de combate e controle da pandemia.


Los datos de seroprevalencia proporcionan información relevante relacionada con el desarrollo y la progresión de la pandemia del COVID-19. El objetivo fue estimar la prevalencia de anticuerpos anti-SARS-CoV-2 en Mato Grosso, Brasil, y su distribución según las características sociodemográficas y económicas. Encuesta seroepidemiológica de base poblacional, realizada entre septiembre y octubre de 2020 con individuos de los 18 años o más en diez municipios del estado de Mato Grosso. Las entrevistas y la recolección de material biológico se realizaron en el domicilio de los participantes, y para la determinación de anticuerpos IgG contra el SARS-CoV-2 se utilizó la quimioluminiscencia. Se evaluaron a 4.306 individuos, y la prevalencia del COVID-19 se estimó en un 12,5% (IC95%: 10,5; 14,7), que van del 7,4% al 24,3% entre los municipios. No se encontraron diferencias en la prevalencia de infección según la raza/color de la piel, la educación o los ingresos familiares; sin embargo, se encontró una menor prevalencia entre los individuos que vivían con un residente que recibía una pensión, que no recibía ayuda económica de emergencia y que los ingresos familiares no disminuyeron tras las medidas de distanciamiento social para hacer frente a la pandemia. La prevalencia de anticuerpos contra el SARS-CoV-2 estimada en esta investigación de base poblacional es imprescindible para conocer la magnitud de la enfermedad en el estado y subvencionar las acciones de enfrentamiento y control de la pandemia.


Subject(s)
COVID-19 , SARS-CoV-2 , Antibodies, Viral , Brazil/epidemiology , COVID-19/epidemiology , Humans , Pandemics , Prevalence , Seroepidemiologic Studies
10.
Clin Nutr ESPEN ; 49: 348-356, 2022 06.
Article in English | MEDLINE | ID: covidwho-1872986

ABSTRACT

BACKGROUND AND AIMS: Consumption of ultra-processed foods is negatively associated with health outcomes, however, the contribution to sleep quality is limited. Therefore, the objective of this study was to evaluate the association between food intake by frequency and degree of processing and sleep quality in adults during the covid-19 pandemic. METHODS: Population-based survey of adults from October to December 2020 in the Iron Quadrangle region, Brazil. The exposure variable was a food intake score that considered the frequency of consumption and food processing degree. The total score ranged from 0 (best) to 48 points (worst food quality), categorized into quartiles. Furthermore, we also evaluated whether individuals replaced their lunch and/or dinner based mostly on fresh/minimally processed foods for ultra-processed foods, for five or more days in the week. The outcome variable was sleep quality assessed with the Pittsburgh Sleep Quality Index. We constructed a contrasting directed acyclic graph (DAG) model to estimate the adjusted odds ratio of the association between score eating and sleep, by logistic regression. RESULTS: Most of the 1762 individuals evaluated had poor sleep quality (52.5%). The minimum and maximum food scores were 0 and 30 points (mean 9.16; 95% CI 8.50, 9.81). The higher values of the score corresponded to lower consumption of fresh and minimally processed foods and higher consumption of ultraprocessed foods. In multivariate analysis, individuals in the third food consumption score had 71% greater odds of poor sleep quality (OR = 1.71; 95% CI: 1.03, 2.85) and in the fourth quartile 144% greater odds (OR = 2.44; 95% CI: 1.32, 2.44). Besides, replacing the dinner meal with ultra-processed foods five days or more in the week was also associated with poor sleep quality (OR = 2.01; 95%CI: 1.14, 3.57). CONCLUSION: Higher consumption of ultra-processed foods concomitant with lower consumption of fresh and minimally processed foods is associated with a higher chance of poor sleep quality.


Subject(s)
COVID-19 , Adult , Fast Foods/adverse effects , Food Handling , Humans , Pandemics , Sleep Quality
11.
Aging Ment Health ; 26(5): 898-904, 2022 05.
Article in English | MEDLINE | ID: covidwho-1221407

ABSTRACT

Objectives: This study aimed at estimating the pre-pandemic and pandemic prevalence of loneliness and investigating the association of loneliness with social disconnectedness during social distancing strategies in the time of the COVID-19 pandemic period.Methods: We used data from the ELSI COVID-19 initiative with participants from the Brazilian Longitudinal Study of Aging (ELSI-Brazil), which comprised 4,431 participants aged 50 years and over. Loneliness (hardly ever/some of the time/often) was assessed by the question "In the past 30 days, how often did you feel alone/lonely?". Social disconnectedness included information on social contacts through virtual talking (i.e. telephone, Skype, WhatsApp, or social media) and outside-home meetings with people living in another household. Covariates included sociodemographic and health related characteristics. Multinomial logistic regression models were used to estimate odds ratios (OR) with their 95% confidence interval (CI).Results: The overall prevalence of loneliness during the pandemic was 23.9% (95% CI 20.7-27.5); lower than in the pre-pandemic period (32.8%; 95% CI 28.6-37.4). In the pandemic period, 20.1% (95% CI 16.9-23.6) reported some of the time feeling lonely and 3.9% (95% CI 3.1-4.8) reported often feeling lonely. In the fully adjusted model, virtual talking disconnectedness (OR=1.67; 95% CI 1.09-2.56) was positively associated with some of the time feeling lonely and outside-home disconnectedness (OR=0.33; 95% CI 0.18-0.60) was negatively associated with often feeling lonely.Conclusion: Individuals with virtual talking disconnectedness and without outside-home disconnectedness are at higher risk of loneliness during the time of COVID-19 pandemic. Stimulating virtual talking connectedness might have the potential to diminish loneliness despite steep outside-home disconnectedness.


Subject(s)
COVID-19 , Loneliness , Aged , Brazil/epidemiology , COVID-19/epidemiology , Humans , Longitudinal Studies , Middle Aged , Pandemics
12.
Psychol Health Med ; 27(1): 42-53, 2022 01.
Article in English | MEDLINE | ID: covidwho-1066127

ABSTRACT

This study aimed to evaluate the stress perception among Brazilian physical therapists (PTs) during COVID-19 pandemic and to identify which psychosocial demands, sociodemographic, professional and clinical factors do associate with the PTs' stress perception. This cross-sectional survey was based on a convenience sample of PTs, who answered a questionnaire about: 1) sociodemographic and professional characteristics, 2) clinical characteristics and information related to COVID-19, 3) psychosocial demands, and 4) 10-item Perceived Stress Scale (PSS-10). Full responses were obtained from 417 PTs. The average PSS-10 score was 19.2 (95% CI 18.5 to 19.9), which was higher than in other Brazilians before COVID-19 and figured among the highest one observed in healthcare workers from different countries during COVID-19 pandemic. After multivariate analysis, PTs' perceived stress remained associated with female sex, younger age, previous diagnosis of depressive or anxiety disorder, worsening in sleep patterns, large reduction in family income, housework, relationship with the partner, concern about close people/family members being infected by SARS-CoV-2, and loneliness.


Subject(s)
COVID-19 , Physical Therapists , Anxiety , Cross-Sectional Studies , Depression , Female , Humans , Pandemics , Perception , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL